Alkem Laboratories is all set to launch a semaglutide injection under the brand names Semasize, Obesema and Hepaglide priced ...

India, March 21 -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma" and includes its subsidiaries and/or associate companies) today ...

March 17 () - Indian drugmakers Zydus Lifesciences and Lupin have signed a licensing and supply ‌deal on Tuesday to co‑market ...

Zydus Lifesciences Limited (including its subsidiaries, hereafter referred to as "Zydus"), an innovation-led global lifesciences company, has launched Semaglutide Injection under the brand names - ...

Leading Sun Pharmaceutical Industries, Zydus Lifesciences and Dr Reddy's Laboratories have launched generic semaglutide injections in India, offering more affordable treatment options for patients ...

With semaglutide going off patent in India, copycat versions of Novo Nordisk’s blockbuster drugs are set to arrive at ...

Zydus Lifesciences has launched Semaglutide Injection under the brand names SEMAGLYN, MASHEMA and ALTERME, upon patent expiry in India. The Drug Controller General of India (DCGI) had earlier provided ...

Natco Pharma has launched the Semaglutide injection in India on the first day of its patent expiry. Hyderabad-based Natco ...

Natco Pharma plans to launch a semaglutide injection, the key ingredient in Novo Nordisk’s Ozempic and Wegovy, at a starting ...

Natco Pharma said the multi-dose vial format is priced around 70% lower than pen devices and nearly 90% cheaper than the innovator product, aimed at improving patient access and long-term treatment ...

As part of the deal, Lupin will pay Zydus upfront licensing fees and milestone-based payments linked to predefined targets.

Zydus Lifesciences has announced the launch of semaglutide injection in India under the brand names Semaglyntm, Mashematm, and Altermetm, following the expiry of the drug's patent in the country.